Clinical Trial Update: Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating concurrent chemoradiotherapy with paclitaxel and cisplatin, with or without Tarceva (erlotinib), in locally advanced esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)
• Tarceva (erlotinib)

Snippet

Sponsor: Wenzhou Medical University | Conditions: Esophageal Cancer | Phase 3 | Status: UNKNOWN